Centiva Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $758K | Buy |
+13,795
| New | +$758K | 0.01% | 516 |
|
|
2025
Q1 | – | Sell |
-3,544
| Closed | -$233K | – | 1362 |
|
|
2024
Q4 | $233K | Sell |
3,544
-3,967
| -53% | -$261K | ﹤0.01% | 982 |
|
|
2024
Q3 | $528K | Buy |
+7,511
| New | +$528K | 0.01% | 788 |
|
|
2024
Q2 | – | Sell |
-2,630
| Closed | -$230K | – | 1578 |
|
|
2024
Q1 | $230K | Buy |
+2,630
| New | +$230K | 0.01% | 1058 |
|
|
2023
Q3 | – | Sell |
-2,341
| Closed | -$203K | – | 1240 |
|
|
2023
Q2 | $203K | Buy |
2,341
+251
| +12% | +$21.8K | ﹤0.01% | 955 |
|
|
2023
Q1 | $203K | Sell |
2,090
-20,985
| -91% | -$2.04M | 0.01% | 853 |
|
|
2022
Q4 | $2.39M | Sell |
23,075
-9,863
| -30% | -$1.02M | 0.07% | 137 |
|
|
2022
Q3 | $2.79M | Buy |
32,938
+2,728
| +9% | +$231K | 0.05% | 130 |
|
|
2022
Q2 | $2.5M | Buy |
30,210
+4,460
| +17% | +$370K | 0.06% | 169 |
|
|
2022
Q1 | $1.99M | Buy |
+25,750
| New | +$1.99M | 0.04% | 228 |
|
|
2021
Q4 | – | Sell |
-29,301
| Closed | -$2.26M | – | 785 |
|
|
2021
Q3 | $2.26M | Sell |
29,301
-7,817
| -21% | -$604K | 0.14% | 123 |
|
|
2021
Q2 | $3.1M | Sell |
37,118
-4,288
| -10% | -$358K | 0.07% | 69 |
|
|
2021
Q1 | $3.13M | Buy |
41,406
+11,106
| +37% | +$838K | 0.12% | 30 |
|
|
2020
Q4 | $2.66M | Buy |
+30,300
| New | +$2.66M | 0.1% | 48 |
|
|
2020
Q1 | – | Sell |
-2,397
| Closed | -$203K | – | 382 |
|
|
2019
Q4 | $203K | Buy |
+2,397
| New | +$203K | 0.01% | 382 |
|